Review: could Tysabri cause Dental Caries?


Summary

Dental caries is found among people who take Tysabri, especially for people who are female, 50-59 old , have been taking the drug for 2 - 5 years, also take medication Avonex, and have Multiple sclerosis . We study 139,605 people who have side effects while taking Tysabri from FDA and social media. Among them, 135 have Dental caries. Find out below who they are, when they have Dental caries and more.

You are not alone

Join a support group for people who take Tysabri and have Dental caries >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Tysabri

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. (latest outcomes from Tysabri 139,770 users)

Dental Caries

Dental caries has been reported by people with breathing difficulty, hypotension, hypokalemia, gastric ulcer, initial insomnia (latest reports from 9,252 Dental caries patients).

On Aug, 29, 2016

139,605 people reported to have side effects when taking Tysabri.
Among them, 135 people (0.1%) have Dental Caries


Number of reports submitted per year:

Could Tysabri cause Dental caries?

Time on Tysabri when people have Dental Caries *:

  • < 1 month: 12.5 %
  • 1 - 6 months: 8.33 %
  • 6 - 12 months: 16.67 %
  • 1 - 2 years: 12.5 %
  • 2 - 5 years: 41.67 %
  • 5 - 10 years: 8.33 %
  • 10+ years: 0.0 %

Gender of people who have Dental Caries when taking Tysabri *:

  • female: 76.87 %
  • male: 23.13 %

Age of people who have Dental Caries when taking Tysabri *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.96 %
  • 20-29: 2.88 %
  • 30-39: 14.42 %
  • 40-49: 28.85 %
  • 50-59: 40.38 %
  • 60+: 12.5 %

Top conditions involved for these people *:

  • Multiple Sclerosis (130 people)
  • Convulsion (8 people)
  • Dyskinesia (6 people)
  • Osteoporosis (5 people)
  • Depression (4 people)

Top co-used drugs for these people *:

  • Avonex (20 people)
  • Klonopin (6 people)
  • Zometa (5 people)
  • Zocor (5 people)
  • Aspirin (5 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Dental caries when taking Tysabri?

Browse all side effects of Tysabri

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Dental caries

Dental caries

Could your condition cause Dental caries

Dental caries

Can you answer these questions?

More questions for: Tysabri, Dental caries

You may be interested in these reviews

More reviews for: Tysabri, Dental caries


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.